News
NXGL
0.6325
+23.78%
0.1215
NexGel announces data from institutional review board clinical study
TipRanks · 10h ago
NEXGEL Announces Data From Randomized, 30-Patient, Single-Center IRB Clinical Study, Funded By Innovative Optics
Benzinga · 10h ago
Nexgel hydrogel patch study cuts laser hair removal plume concentration 95.6%
PUBT · 10h ago
NEXGEL REPORTS POSITIVE DATA FROM RANDOMIZED SINGLE-CENTER IRB STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF A HYDROGEL LASER TREATMENT PATCH IN LASER HAIR REMOVAL WITH A 95.6% REDUCTION IN PLUME CONCENTRATION
Reuters · 10h ago
Nexgel director Kevin McClain Harris files initial beneficial ownership statement
PUBT · 23h ago
Nexgel director Brian Kieser files initial beneficial ownership statement
PUBT · 23h ago
Weekly Report: what happened at NXGL last week (0511-0515)?
Weekly Report · 1d ago
Nexgel Earnings Call: BioNX Bet Amid Cash Strain
TipRanks · 3d ago
NexGel Raises Insider-Funded Convertible Notes to Bolster Liquidity
TipRanks · 4d ago
NexGel raises $1.21 million via convertible notes private placement
PUBT · 4d ago
Nexgel (NXGL) Q1 2026 Earnings Transcript
NASDAQ · 4d ago
NexGel Q1 2026 Earnings Call Transcript
Benzinga · 4d ago
NEXGEL GAAP EPS of -$0.11 misses by $0.04, revenue of $2.65M misses by $1.26M
Seeking Alpha · 4d ago
NEXGEL APPOINTS DAVE HAZARD AS VICE PRESIDENT OF SALES FOR BIONX SURGICAL
Reuters · 6d ago
NEXGEL Strengthens Board with Sequence LifeScience Leaders
TipRanks · 05/12 22:29
Nexgel appoints Sequence LifeScience CEO Kieser, COO Harris to board
PUBT · 05/12 20:32
Nexgel to report first-quarter results, host conference call
PUBT · 05/12 14:27
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Barchart · 05/12 09:27
Weekly Report: what happened at NXGL last week (0504-0508)?
Weekly Report · 05/11 09:26
Nexgel files initial beneficial ownership statement for CFO Ian Howard Blackman
PUBT · 05/07 20:50
More
Webull provides a variety of real-time NXGL stock news. You can receive the latest news about Nexgel Inc through multiple platforms. This information may help you make smarter investment decisions.
About NXGL
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises is comprised of the CGN JV used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George. It also holds a portfolio of regenerative biomaterials which include Biovance, Biovance 3L, Natalin, and others.